Professional Membership
ESMO, ESTRO, RSM, BIR, ASCO
Treatment information
Oncology
Year Qualified
1979
Professional profile
Dr Robert Glynne-Jones is Consultant Clinical Oncologist at Mount Vernon
Hospital, Watford and Barnet General Hospitals in London, where he is the
Macmillan Lead Clinician in Gastrointestinal and Colorectal Cancer.
Dr Glynne-Jones is also Chief Medical Advisor to the national UK charity Bowel
Cancer UK, and has a major interest in communications skills and patient
choice.
He is a member of the European Society for Therapeutic Radiology and Oncology,
the EORTC, ESMO and the American Society of Clinical Oncology. He plays an
active role in the UK NCRI colorectal research group.
In the past he has been a member of NICE committees responsible for guidance
for colorectal cancer and for producing quality standards for colorectal
cancer, and is currently a member of a NICE committee examining Lynch syndrome
and mismatch repair testing.
His major research interest is in rectal and anal cancer and in phase I, and
translational research in chemoradiation.
He has more than 150 peer reviewed publications.
Current areas of research include the integration of immune checkpoint
inhibitors into chemoradiation schedules in anal cancer and rectal cancer, the
investigation of predictive factors for response and resistance to
chemoradiation in anal and rectal cancer, DCE-MRI changes, and the optimal
timing for surgery after chemoradiation.
Current NHS posts
Clinical oncologist at Mount Vernon Centre for Cancer Treatment.
